Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Change in Receivables (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Change in Receivables for 4 consecutive years, with -$254000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables changed N/A year-over-year to -$254000.0, compared with a TTM value of $891000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $1.1 million, changed N/A over the prior year.
  • Change in Receivables was -$254000.0 for Q3 2025 at X4 Pharmaceuticals, down from $636000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.1 million in Q4 2024 and bottomed at -$561000.0 in Q1 2025.